The Division of Chronic Pain Management is part of a larger multidisciplinary pain management program at UW Health comprised of specialists in anesthesiology, physical medicine and rehabilitation, psychiatry, psychology and physical therapy. In addition to treating all chronic pain conditions with the most advanced modalities and technologies, we also provide a second-opinion service, eConsults and telemedicine services.
As affiliates of one of the country’s largest pain management clinics, we are able to provide services to regional clinics throughout southern Wisconsin in collaboration with other health systems. Our division also provides cancer pain services throughout the state.
The Division of Chronic Pain Management directs clinical rotations for residents in a variety of specialties including anesthesiology, psychiatry, addiction medicine, primary care and internal medicine. We co-direct an accredited chronic pain fellowship program with the UW School of Medicine and Public Health Department of Orthopedics and Rehabilitation. We also host rotating medical students and undergraduate students interested in this field.
Members of our division conduct pain management research and clinical trials, contribute to textbooks and deliver regional lectures. We have participated in U.S. Food and Drug Administration trials and are currently conducting a systematic review to evaluate the efficacy of lumbar medial branch radiofrequency ablation.
Two of our faculty members, Drs. Timothy Casias and Srinivas Naidu, provide pediatric services as members of the Divisions of Chronic Pain Management and Pediatric Anesthesiology. Faculty in our growing adult chronic pain include: Dr. Alaa Abd-Elsayed, the current medical director of UW Health Pain Management; Dr. Keth Pride, associate director of the chronic pain fellowship program; and Dr. Roy Kim.
Dr. Alaa Abd-Elsayed pursues state-of-the-art clinical strategies to reduce chronic pain and manage general pain treatment. With an emphasis on treating the whole patient and carefully considering the pathology of their pain, his team is able to dramatically improve quality of life with advanced technologies and modalities that successfully reduce or block pain.
Dr. Abd-Elsayed’s clinical trial titled “RePRIEVE-CM (achieving Radicular Pain RelIEf Via Epidural Injection of Clonidine Micropellets)” is a prospective, multicenter, randomized, double-blind, sham-controlled study that evaluates the effect and safety of clonidine in treating radicular leg pain when delivered via micropellet depot into the lumbar epidural space.
Alaa Abd-Elsayed, MD, MPH
Pain Dyad, Director of Chronic Pain, and Assistant Professor